Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2013-01-14

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2013-01-14 (fiscal Q3 2012): 37 published measures, 99 facts as tagged in accession 0001161697-13-000045.

This filing

Form
10-Q (quarterly report)
Filed
2013-01-14
Fiscal period
fiscal Q3 2012
Accession
0001161697-13-000045 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-11-305,401,520USD
At 2012-02-294,805,145USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-11-301,314,235USD
At 2012-02-291,254,417USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-11-304,087,285USD
At 2012-02-293,550,728USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-11-301,682,341USD
At 2012-02-291,757,223USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2012-11-3055,524USD91
2012-03-01 to 2012-11-30496,507USD275
2011-09-01 to 2011-11-30182,247USD91
2011-03-01 to 2011-11-30498,279USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-03-01 to 2012-11-30503,591USD275
2011-03-01 to 2011-11-30258,314USD275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-03-01 to 2012-11-30544,705USD275
2011-03-01 to 2011-11-30203,407USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-03-01 to 2012-11-30-32,372USD275
2011-03-01 to 2011-11-30289,980USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-03-01 to 2012-11-30-546,101USD275
2011-03-01 to 2011-11-30-304,940USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-11-30551,274USD
At 2012-02-2954,767USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-09-01 to 2012-11-3036,611,667shares91
2012-03-01 to 2012-11-3035,798,649shares275
2011-09-01 to 2011-11-3038,602,667shares91
2011-03-01 to 2011-11-3037,343,845shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-09-01 to 2012-11-3036,661,667shares91
2012-03-01 to 2012-11-3035,831,717shares275
2011-09-01 to 2011-11-3038,698,821shares91
2011-03-01 to 2011-11-3038,446,984shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-09-01 to 2012-11-300USD/shares91
2012-03-01 to 2012-11-300.01USD/shares275
2011-09-01 to 2011-11-300USD/shares91
2011-03-01 to 2011-11-300.01USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-09-01 to 2012-11-300USD/shares91
2012-03-01 to 2012-11-300.01USD/shares275
2011-09-01 to 2011-11-300USD/shares91
2011-03-01 to 2011-11-300.01USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-09-01 to 2012-11-3028,957USD91
2012-03-01 to 2012-11-30258,049USD275
2011-09-01 to 2011-11-30127,169USD91
2011-03-01 to 2011-11-30347,694USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-11-30912,162USD
At 2012-02-29498,940USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-09-01 to 2012-11-3040,050USD91
2012-03-01 to 2012-11-3040,050USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-09-01 to 2012-11-3087,391USD91
2012-03-01 to 2012-11-30775,505USD275
2011-09-01 to 2011-11-30226,197USD91
2011-03-01 to 2011-11-30737,045USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-11-304,411,192USD
At 2012-02-294,253,536USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-09-01 to 2012-11-307,105USD91
2012-03-01 to 2012-11-3021,491USD275
2011-09-01 to 2011-11-308,200USD91
2011-03-01 to 2011-11-3024,099USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-11-30669,735USD
At 2012-02-29558,853USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-11-30203,458USD
At 2012-02-29199,527USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-11-301,187,961USD
At 2012-02-29884,727USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-11-301,170,220USD
At 2012-02-291,167,456USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-09-01 to 2012-11-301,112,727USD91
2012-03-01 to 2012-11-302,657,929USD275
2011-09-01 to 2011-11-30631,976USD91
2011-03-01 to 2011-11-301,875,092USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-09-01 to 2012-11-3036,062USD91
2012-03-01 to 2012-11-30111,452USD275
2011-09-01 to 2011-11-3026,606USD91
2011-03-01 to 2011-11-3049,302USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-11-3036,661,667shares
At 2012-02-2935,196,667shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-11-3022,197USD
At 2012-02-2924,513USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-11-3078,166USD
At 2012-02-2952,669USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-11-30155,331USD
At 2012-02-29153,800USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-09-01 to 2012-11-3084,481USD91
2012-03-01 to 2012-11-30754,556USD275
2011-09-01 to 2011-11-30309,416USD91
2011-03-01 to 2011-11-30845,973USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-09-01 to 2012-11-3051,329USD91
2012-03-01 to 2012-11-30134,799USD275
2011-09-01 to 2011-11-3027,113USD91
2011-03-01 to 2011-11-3073,391USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-09-01 to 2012-11-30-2,910USD91
2012-03-01 to 2012-11-30-20,949USD275
2011-09-01 to 2011-11-3083,219USD91
2011-03-01 to 2011-11-30108,928USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-03-01 to 2011-11-30121,500USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-11-30303,234USD275
2011-03-01 to 2011-11-30164,257USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-11-302,764USD275
2011-03-01 to 2011-11-30393,726USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-11-303,931USD275
2011-03-01 to 2011-11-30151,638USD275

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))